The world is currently asking a central question: When will a corona vaccine be released that will end the pandemic?
Now there seems to be a breakthrough.
Hamm - New infections with the
coronavirus
* increase with the number of hotspots in Germany.
The end of the pandemic is far from in sight.
Wearing masks is now normal - at least for most of them.
The hoped-for salvation thanks to a
vaccine
is a long time coming - until now.
There seems to be a new
breakthrough
, as
WA.de
* writes.
vaccine | BNT162b2 |
Companies | Biontech |
Seat | Marburg |
The world is longingly waiting for a corona vaccine.
More than a million
coronavirus sufferers
have died so far.
In Germany alone there were more than 331,132 infected people (as of October 13, 2020).
A curfew was set up in Hamm on Tuesday *.
Researchers have been working hard on a
vaccine
against the
coronavirus
since around the new year
.
The World Health Organization currently has
193 vaccine projects
.
Corona vaccine: Breakthrough at Biontech - vaccinations possible in winter
The success?
Manageable.
After
AstraZeneca
, another major pharmaceutical
company
had to suspend an important
vaccine study
.
As the US drug manufacturer
Johnson & Johnson announced
, the
study was
temporarily
stopped
on Monday due to an unexplained
illness in
a subject.
Particularly bitter: The US company originally belonged to the very group from which the EU Commission
secured
hundreds of millions of
vaccine
doses because only one dose would be enough.
Others, however, require a second vaccination.
Does salvation come from Germany of all places?
The city of Bochum would be happy, it is on the way to the risk area *.
Corona vaccine: Breakthrough at Biontech - vaccinations possible in winter
As reported by
n-tv
, the newly developed
vaccine BNT162b2 by
the pharmaceutical company
Biontech
has successfully completed clinical trials.
The
mass production
has already begun, the final permit application is already pending.
It is said that one is on the verge of "putting an end to this pandemic".
The
vaccine
is now being tested in the so-called rolling review process in Amsterdam.
In April,
Biontech
was the first German company to receive approval to conduct clinical studies.
Around 37,000 participants have now been included in the study, 28,000 of whom have already received the second dose.
+
How does a possible corona vaccine affect everyday life?
© Christoph Schmidt / dpa
The
corona vaccine BNT162b2
has "an excellent profile," says Biontech boss Ugur Sahin in an interview with the
Frankfurter Allgemeine Zeitung
.
In addition, you are "slowly approaching the home straight," said Sahin.
The first
corona vaccinations
could already start in winter - regardless of the flu vaccinations recommended by experts.
And that without a long start-up phase.
"If all horses cross the finish line, we will have way too much
vaccine
," said Federal Health Minister Jens Spahn.
Corona vaccine: Biontech expects 350 million corona vaccine doses by summer 2021
It was only in September that
Biontech took over
the premises of the Swiss pharmaceutical giant Novartis with 300 highly qualified employees in order to expand the production of the
corona vaccine
.
Biontech
is planning 100 million
Corona
vaccination doses
this year, with another 250 million to follow in the first half of 2021.
Will everyday life then return to Germany and throw the mouth and nose protection in the trash?
The Robert Koch Institute is dampening initial expectations.
Even with the introduction of the
corona vaccine
, everyday life will initially remain restricted, according to
the RKI's
new
strategy paper
.
The
vaccination
was indeed "an important part of pandemic-fighting".
Nevertheless, measures would have to be adapted to the respective risk.
* wa.de is part of the Ippen-Digital network.
List of rubric lists: © Christoph Schmidt / dpa